Literature DB >> 19869696

THE REFRACTORY PERIOD OF THE NORMALLY-BEATING DOG'S AURICLE; WITH A NOTE ON THE OCCURRENCE OF AURICULAR FIBRILLATION FOLLOWING A SINGLE STIMULUS.

E C Andrus1, E P Carter.   

Abstract

1. A method is described for determining the refractory period of the dog's auricle during the normal sinus rhythm. The advantages of the method are: (a) The total stimulating effects of repeated induction shocks are avoided. (b) The action current is recorded from a point one millimeter or less from the point of stimulation. (c) Alterations in the spontaneous rate of the auricle do not interfere with the accurate determination of the refractory period. 2. The values obtained for the normal refractory period and the changes produced by atropine and by stimulation of the vagus agree closely with those of previous observers. 3. The automatic features of the method make possible the determination of the refractory period under adrenalin. This drug brings about a distinct shortening of the refractory period but less than that produced by stimulation of the vagus. 4. During vagal stimulation a single induction shock, introduced soon after the end of the refractory period, frequently produces auricular fibrillation. The cause of this irregularity is discussed and its relation to clinical auricular fibrillation is suggested.

Entities:  

Year:  1930        PMID: 19869696      PMCID: PMC2131830          DOI: 10.1084/jem.51.3.357

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  [Influence of spontaneous heart collaterals on arrhythmias following acute experimental coronary occlusion].

Authors:  G Schley; W Meesmann; F W Schulz; L Amann; J Tüttemann; A Wilde
Journal:  Arch Kreislaufforsch       Date:  1972-12

2.  [The vulnerability of the right atrium. II. Correlations between vulnerability and the atrial refractory periods (author's transl)].

Authors:  T Pop; D Fleischmann; S Effert
Journal:  Klin Wochenschr       Date:  1977-01-15

Review 3.  Arrhythmias and vagus nerve stimulation.

Authors:  Youhua Zhang; Todor N Mazgalev
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

4.  The vulnerability of the right atrium. III. Electrophysiologic correlates of atrial vulnerability.

Authors:  T Pop; D Fleischmann; S Effert
Journal:  Klin Wochenschr       Date:  1979-01-01

5.  TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial.

Authors:  Stavros Stavrakis; Julie A Stoner; Mary Beth Humphrey; Lynsie Morris; Adrian Filiberti; Justin C Reynolds; Khaled Elkholey; Isma Javed; Nicholas Twidale; Pavel Riha; Subha Varahan; Benjamin J Scherlag; Warren M Jackman; Tarun W Dasari; Sunny S Po
Journal:  JACC Clin Electrophysiol       Date:  2020-01-29

6.  [The vulnerability of the human atrium. I. Correlations between vulnerability, sinus node recovery time and intraatrial conduction time (author's transl)].

Authors:  T Pop; D Fleischmann; S Effert
Journal:  Klin Wochenschr       Date:  1976-09-01

Review 7.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 8.  Neuroscientific therapies for atrial fibrillation.

Authors:  Peter Hanna; Eric Buch; Stavros Stavrakis; Christian Meyer; John D Tompkins; Jeffrey L Ardell; Kalyanam Shivkumar
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

9.  Auricular excitability of the normal dog heart.

Authors:  D ASHWORTH; L H NAHUM
Journal:  Yale J Biol Med       Date:  1954-12

10.  Modeling effects of voltage dependent properties of the cardiac muscarinic receptor on human sinus node function.

Authors:  Robin Moss; Frank B Sachse; Eloy G Moreno-Galindo; Ricardo A Navarro-Polanco; Martin Tristani-Firouzi; Gunnar Seemann
Journal:  PLoS Comput Biol       Date:  2018-10-10       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.